Host defenses against metabolic endotoxaemia and their impact on lipopolysaccharide detection

References

• Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001;7:167–202.
   PubMedGoogle Scholar
• Gnauck A, Lentle RG, Kruger MC. The characteristics and function of bacterial lipopolysaccharides and their endotoxic potential in humans. Int Rev Immunol 2015;25:1–31.
   PubMed Web of Science ®Google Scholar
• Krogh-Madsen R, Plomgaard P, Akerstrom T, et al. Effect of short-term intralipid infusion on the immune response during low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2008;294:E371–E379.
   PubMed Web of Science ®Google Scholar
• DuBose D, Lemaire M, Brown J, et al. Survey for positive Limulus amoebocyte lysate test in plasma from humans and common research animals. J Clin Microbiol 1978;7:139–141.
   PubMed Web of Science ®Google Scholar
• Goto T, Eden S, Nordenstam G, et al. Endotoxin levels in sera of elderly individuals. Clin Diagnost Lab Immunol 1994;1:684–688.
   PubMedGoogle Scholar
• Brandtzaeg P, Bryn K, Kierulf P, et al. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest 1992;89:816–823.
   PubMed Web of Science ®Google Scholar
• Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001;16:83–96.
   PubMed Web of Science ®Google Scholar
• Wiedermann CI, Kiechl S, Dunzendorfer S, et al. Association of endotoxaemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 1999;34:1975–1981.
   PubMed Web of Science ®Google Scholar
• Pussinen PJ, Tuomisto K, Jousilahti P, et al. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007;27:1433– 1439.
   PubMed Web of Science ®Google Scholar
• Szeto CC, Kwan BC, Chow KM, et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 2008;3:431–436.
   PubMed Web of Science ®Google Scholar
• Creely SJ, McTernan PG, Kusminski CM, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007;292:E740–E747.
   PubMed Web of Science ®Google Scholar
• Al-Attas OS, Al-Daghri NM, Al-Rubeaan KA, et al. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol 2009;8:20.
   PubMed Web of Science ®Google Scholar
• Pussinen PJ, Havulinna AS, Lehto M, et al. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011;34:392–397.
   PubMed Web of Science ®Google Scholar
• Trøseid M, Nestvold TK, Rudi K, et al. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care 2013;36:3627– 3632.
   PubMed Web of Science ®Google Scholar
• Thuy S, Ladurner R, Volynets V, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008;138:1452–1455.
   PubMed Web of Science ®Google Scholar
• Harte AL, da Silva NF, Creely SJ, et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond) 2010;7:15.
   PubMed Web of Science ®Google Scholar
• Kapil S, Duseja A, Sharma BK, et al. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2016;31:213–221.
   PubMed Web of Science ®Google Scholar
• Cuaz-Pérolin C, Billiet L, Baugé E, et al. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE−/− mice. Arterioscler Thromb Vasc Biol 2008;28:272–277.
   PubMed Web of Science ®Google Scholar
• Malik TH, Cortini A, Carassiti D, et al. The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2010;122:1948–1956.
   PubMed Web of Science ®Google Scholar
• Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761–1772.
   PubMed Web of Science ®Google Scholar
• Mehta NN, McGillicuddy FC, Anderson PD, et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 2010;59:172–181.
   PubMed Web of Science ®Google Scholar
• Michelson KS, Wong MH, Shah PK, et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004;101:10679–10684.
   PubMed Web of Science ®Google Scholar
• Shi H, Kokoeva MV, Inouye K, et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015–3025.
   PubMed Web of Science ®Google Scholar
• Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007;56:1986–1998.
   PubMed Web of Science ®Google Scholar
• Herieka M, Faraj TA, Erridge C. Reduced dietary intake of pro-inflammatory Toll-like receptor stimulants favourably modifies markers of cardiometabolic risk in healthy men. Nutr Metab Cardiovasc Dis 2016;26:194–200.
   PubMed Web of Science ®Google Scholar
• Ghoshal S, Witta J, Zhong J, et al. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009;50:90–97.
   PubMed Web of Science ®Google Scholar
• Erridge C, Attina T, Spickett CM, et al. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007;86:1286–1292.
   PubMed Web of Science ®Google Scholar
• Ghanim H, Sia CL, Upadhyay M, et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr 2010;91:940–949.
   PubMed Web of Science ®Google Scholar
• van Deventer SJ, Buller HR, ten Cate JW, et al. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990;76:2520–2526.
   PubMed Web of Science ®Google Scholar
• Coulthard MG, Swindle J, Munford RS, et al. Adenovirus-mediated transfer of a gene encoding acyloxyacyl hydrolase (AOAH) into mice increases tissue and plasma AOAH activity. Infect Immun 1996;64:1510–1515.
   PubMed Web of Science ®Google Scholar
• Gnauck A, Lentle RG, Kruger MC. Chasing a ghost?—Issues with the determination of circulating levels of endotoxin in human blood. Crit Rev Clin Lab Sci 2016;53:197–215.
   PubMed Web of Science ®Google Scholar
• Erridge C, Bennett-Guerrero E, Poxton IR. Structure and function of lipopolysaccharides. Microbes Infect 2002;4:837–851.
   PubMed Web of Science ®Google Scholar
• Rietschel ET, Kirikae T, Schade U, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994;8:217–225.
   PubMed Web of Science ®Google Scholar
• Poxton I. Antibodies to lipopolysaccharide. J Immunol Methods 1995;186:1–15.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373–384.
   PubMed Web of Science ®Google Scholar
• Park BS, Song DH, Kim HM, et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009;458:1191– 1195.
   PubMed Web of Science ®Google Scholar
• Ohto U, Fukase K, Miyake K, et al. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc Natl Acad Sci USA 2012;109:7421–7426.
   PubMed Web of Science ®Google Scholar
• Kim HM, Park BS, Kim JI, et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 2007;130:906–917.
   PubMed Web of Science ®Google Scholar
• Paramo T, Piggot TJ, Bryant CE, et al. The structural basis for endotoxin-induced allosteric regulation of the Toll-like receptor 4 (TLR4) innate immune receptor. J Biol Chem 2013;288:36215–36225.
   PubMed Web of Science ®Google Scholar
• Berg RD.The indigenous gastrointestinal microflora. Trends Microbiol 1996;4:430–435.
   PubMed Web of Science ®Google Scholar
• Lindberg AA, Weintraub A, Zahringer U, et al. Structure–activity relationships in lipopolysaccharides of Bacteroidesfragilis. Rev Infect Dis 1990;12(Supp 2):S133–S141.
   PubMedGoogle Scholar
• Weintraub A, Zahringer U, Wollenweber H-W, et al. Structural characterization of the lipid A component of Bacteroidesfragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem 1989;183:425–431.
   PubMedGoogle Scholar
• Alhawi M, Stewart J, Erridge C, et al. Bacteroidesfragilis signals through Toll-like receptor (TLR) 2 and not through TLR4. J Med Microbiol 2009;58:1015–1022.
   PubMed Web of Science ®Google Scholar
• Magnuson DK, Weintraub A, Pohlmann HT, et al. Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroidesfragilis lipopolysaccharide. J Immunol 1989;143:3025–3030.
   PubMed Web of Science ®Google Scholar
• Vatanen T, Kostic AD, d'Hennezel E, et al. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell 2016;165:842–853.
   PubMed Web of Science ®Google Scholar
• Suffredini AF, Hochstein HD, McMahon FG. Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J Infect Dis 1999;179:1278– 1282.
   PubMed Web of Science ®Google Scholar
• Copeland S, Warren HS, Lowry SF, et al. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 2005;12:60–67.
   PubMedGoogle Scholar
• Krogh-Madsen R, Møller K, Dela F, et al. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-a, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2004;286:E766–E772.
   PubMed Web of Science ®Google Scholar
• Dudele A, Fischer CW, Elfving B, et al. Chronic exposure to low doses of lipopolysaccharide and high-fat feeding increases body mass without affecting glucose tolerance in female rats. Physiol Rep 2015;3:e12584.
   PubMedGoogle Scholar
• Borges B de C, Rorato RC, Uchoa ET, et al. Protein tyrosine phosphatase-1B contributes to LPS-induced leptin resistance in male rats. Am J Physiol Endocrinol Metab 2015;308:E40–E50.
   PubMed Web of Science ®Google Scholar
• Feingold KR, Staprans I, Memon RA, et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 1992;33:1765–1776.
   PubMed Web of Science ®Google Scholar
• McGillicuddy FC, de la Llera Moya M, Hinkle CC, et al. Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009;19:1135–1145.
   Google Scholar
• Kim KA, Gu W, Lee IA, et al. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012;7:e47713.
   PubMed Web of Science ®Google Scholar
• Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010;328:228–231.
   PubMed Web of Science ®Google Scholar
• Poggi M, Bastelica D, Gual P, et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007;50:1267–1276.
   PubMed Web of Science ®Google Scholar
• Radin MS, Sinha S, Bhatt BA, et al. Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 2007;51:336–346.
   PubMed Web of Science ®Google Scholar
• Spruss A, Kanuri G, Wagnerberger S, et al. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 2009;50:1094–1104.
   PubMed Web of Science ®Google Scholar
• Bjorkbacka H, Kunjathoor VV, Moore KJ, et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signalling pathways. Nat Med 2004;10:416–421.
   PubMed Web of Science ®Google Scholar
• Gutsmann T, Howe J, Zähringer U, et al. Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells. Innate Immun 2010;16:39–47.
   PubMed Web of Science ®Google Scholar
• Nakao A, Shinohara M. Changes of circulating blood endotoxin analyzed by quantitative assay after intravenous administration of endotoxin. Jpn J Gastroenterol 1985;82:296–300.
   PubMedGoogle Scholar
• Nakao A, Taki S, Yasui M, et al. The fate of intravenously injected endotoxin in normal rats and in rats with liver failure. Hepatology 1994;19:1251–1256.
   PubMed Web of Science ®Google Scholar
• Haudek SB, Natmessnig BE, Fürst W, et al. Lipopolysaccharide dose response in baboons. Shock 2003;20:431–436.
   PubMed Web of Science ®Google Scholar
• Herring WB, Herion JC, Walker RI, et al. Distribution and clearance of circulating endotoxin. J Clin Invest 1963;42:79–87.
   PubMed Web of Science ®Google Scholar
• Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979;123:2133–2143.
   PubMed Web of Science ®Google Scholar
• Musson RA, Morrison DC, Ulevitch RJ. Distribution of endotoxin (lipopolysaccharide) in the tissues of lipopolysaccharide-responsive and -unresponsive mice. Infect Immun 1978;21:448–457.
   PubMed Web of Science ®Google Scholar
• Rensen PCN, van Oosten M, van de Bilt E, et al. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 1997;99:2438–2445.
   PubMed Web of Science ®Google Scholar
• Wong YN, Rossignol D, Rose JR, et al. Safety, pharmacokinetics and pharmacodynamics of E5564, a lipid A antagonist, during an ascending single-dose clinical study. J ClinPharmacol 2003;43:735–742.
   Google Scholar
• Lynn M, Wong YN, Wheeler JL, et al. Extended in vivo pharmacodynamic activity of E5564 in normal volunteers with experimental endotoxemia. J Pharmacol Exp Ther 2004;308:175–181.
   PubMed Web of Science ®Google Scholar
• Rossignol DP, Wong N, Noveck R, et al. Continuous pharmacodynamic activity of eritorantetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers. Innate Immun 2008;14:383–394.
   PubMed Web of Science ®Google Scholar
• de Bono JS, Dalgleish AG, Carmichael J, et al. Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide. Clin Cancer Res 2000;6:397–405.
   PubMed Web of Science ®Google Scholar
• Rose JR, Mullarkey MA, Christ WJ, et al. Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins. Antimicrob Agents Chemother 2000;44:504–510.
   PubMed Web of Science ®Google Scholar
• Freudenberg MA, Kleine B, Galanos C. The fate of lipopolysaccharide in rats: evidence for chemical alteration in the molecule. Rev Infect Dis 1984;6:483–487.
   PubMedGoogle Scholar
• Victorov AV, Medvedeva NV, Gladkaya EM, et al. Composition and structure of lipopolysaccharide-human plasma low density lipoprotein complex. Analytical ultracentrifugation, 31P-NMR, ESR and fluorescence spectroscopy studies. Biochim Biophys Acta 1989;984:119–127.
   PubMed Web of Science ®Google Scholar
• Levels JHM, Abraham PR, Van den Ende A, et al. Distribution and kinetics of lipoprotein bound endotoxin. Infect Immun 2001;69:2821–2828.
   PubMed Web of Science ®Google Scholar
• Munford RS, Hall CI, Lipton JM, et al. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest 1982;70:877–888.
   PubMed Web of Science ®Google Scholar
• Van Lenten BJ, Fogelman AM, Haberland ME, et al. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1986;83:2704–2708.
   PubMed Web of Science ®Google Scholar
• Vreugdenhil AC, Snoek AM, van't Veer C, et al. LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J Clin Invest 2001;107:225–234.
   PubMed Web of Science ®Google Scholar
• Harris HW, Grunfeld C, Feingold KR, et al. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990;86:696–702.
   PubMed Web of Science ®Google Scholar
• Emancipator K, Csako G, Elin RJ. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun 1992;60:596–601.
   PubMed Web of Science ®Google Scholar
• Read TE, Grunfeld C, Kumwenda ZL, et al. Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med 1995;182:267–272.
   PubMed Web of Science ®Google Scholar
• Flegel WA, Wolpl A, Mannel DN, et al. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun 1989;57:2237–2245.
   PubMed Web of Science ®Google Scholar
• Cavaillon JM, Fitting C, Haeffner-Cavaillon N, et al. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun 1990;58:2375–2382.
   PubMed Web of Science ®Google Scholar
• Netea MG, Demacker PN, Kullberg BJ, et al. Bacterial lipopolysaccharide binds and stimulates cytokine-producing cells before neutralization by endogenous lipoproteins can occur. Cytokine 1998;10:766–772.
   PubMed Web of Science ®Google Scholar
• Levine DM, Parker TS, Donnelly TM, et al. In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA 1993;90:12040–12044.
   PubMed Web of Science ®Google Scholar
• Netea MG, Demacker PN, Kullberg BJ, et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest 1996;97:1366–1372.
   PubMed Web of Science ®Google Scholar
• Harris HW, Grunfeld C, Feingold KR, et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993;91:1028–1034.
   PubMed Web of Science ®Google Scholar
• Read TE, Grunfeld C, Kumwenda Z, et al. Triglyceride-rich lipoproteins improve survival when given after endotoxin in rats. Surgery 1995;117:62–67.
   PubMed Web of Science ®Google Scholar
• Harris HW, Johnson JA, Wigmore SJ. Endogenous lipoproteins impact the response to endotoxin in humans. Crit Care Med 2002;30:23–31.
   PubMed Web of Science ®Google Scholar
• Pajkrt D, Doran JE, Koster F, et al. Anti-inflammatory effects of reconstituted high-density lipoprotein during human endotoxaemia. J Exp Med 1996;184:1601–1608.
   PubMed Web of Science ®Google Scholar
• Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45:1169–1196.
   PubMed Web of Science ®Google Scholar
• Erridge C. Endogenous ligands of TLR2 and TLR4: Agonists or assistants? J Leukoc Biol 2010;87:989–999.
   PubMed Web of Science ®Google Scholar
• Hiki N, Berger D, Dentener MA, et al. Changes in endotoxin-binding proteins during major elective surgery: important role for soluble CD14 in regulation of biological activity of systemic endotoxin. Clin Diagnost Lab Immunol 1999;6:844–850.
   PubMedGoogle Scholar
• Skarnes RC, Rosen FS, Shear MJ, et al. Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma. J Exp Med 1958;108:685–699.
   PubMed Web of Science ®Google Scholar
• Levin J, Tomasulo PA, Oser RS. Detection of endotoxin in human blood and demonstration of an inhibitor. J Lab Clin Med 1970;75:903–911.
   PubMed Web of Science ®Google Scholar
• Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009;30:475–487.
   PubMed Web of Science ®Google Scholar
• Greisman SE, Young EJ, Carozza FA Jr. Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance. J Immunol 1969;103:1223–1236.
   PubMed Web of Science ®Google Scholar
• Baumgartner JD, Heumann D, Calandra T, et al. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5. J Infect Dis 1991;163:769–772.
   PubMed Web of Science ®Google Scholar
• Uddin T, Aktar A, Xu P, et al. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg 2014;90:873–881.
   PubMed Web of Science ®Google Scholar
• Burd RS, Battafarano RJ, Cody CS, et al. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor alpha by 2 distinct mechanisms. Ann Surg 1993;218:250–261.
   PubMed Web of Science ®Google Scholar
• Di Padova F, Brade H, Barclay GR, et al. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect Immun 1993;61:3863–3872.
   PubMed Web of Science ®Google Scholar
• Nys M, Cloes JM, Demonty J, et al. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia. J Infect Dis 1990;162:1087–1095.
   PubMed Web of Science ®Google Scholar
• Bennett-Guerrero E, Barclay GR, Weng PL, et al. Endotoxin-neutralizing capacity of serum from cardiac surgical patients. J Cardiothorac Vasc Anesth 2001;15:451–454.
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004;303:1662–1665.
   PubMed Web of Science ®Google Scholar
• Lim PL, Rowley D. The effect of antibody on the intestinal absorption of macromolecules and on intestinal permeability in adult mice. Int Arch Allergy Appl Immunol 1982;68:41–46.
   PubMedGoogle Scholar
• Konrad A, Cong Y, Duck W, et al. Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota. Gastroenterology 2006;130:2050–2059.
   PubMed Web of Science ®Google Scholar
• Haas A, Zimmermann K, Graw F, et al. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut 2011;60:1506–1519.
   PubMed Web of Science ®Google Scholar
• Hampton RY, Golenbock DT, Penman M, et al. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991;352:342–344.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT, Hendricks PA, Shively JE, et al. Distribution of radiolabeled endotoxin with particular reference to the eye. J Nucl Med 1983;24:29–33.
   PubMed Web of Science ®Google Scholar
• Shao B, Lu M, Katz SC, et al. A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J Biol Chem 2007;282:13726–13735.
   PubMed Web of Science ®Google Scholar
• Maitra SK, Rachmilewitz D, Eberle D, et al. The hepatocellular uptake and biliary excretion of endotoxin in the rat. Hepatology 1981;1:401–407.
   PubMed Web of Science ®Google Scholar
• Praaning-van Dalen DP, Brouwer A, Knook DL. Clearance capacity of rat liver Kupffer, Endothelial, and parenchymal cells. Gastroenterology 1981;81:1036–1044.
   PubMed Web of Science ®Google Scholar
• Van Bossuyt H, De Zanger RB, Wisse E. Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J Hepatol 1988;7:325–337.
   PubMed Web of Science ®Google Scholar
• Freudenberg MA, Freudenberg N, Galanos C. Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Pathol 1982;63:56–65.
   PubMedGoogle Scholar
• Hopf U, Ramadori G, Möller B, et al. Hepatocellular clearance function of bacterial lipopolysaccharides and free lipid A in mice with endotoxic shock. Am J Emerg Med 1984;2:13–19.
   PubMedGoogle Scholar
• Harris HW, Brady SE, Rapp JH. Hepatic endosomal trafficking of lipoprotein-bound endotoxin in rats. J Surg Res 2002;106:188–195.
   PubMed Web of Science ®Google Scholar
• Read TE, Harris HW, Grunfeld C, et al. Chylomicrons enhance endotoxin excretion in bile. Infect Immun 1993;61:3496–3502.
   PubMed Web of Science ®Google Scholar
• Shnyra A, Lindberg AA. Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro. Infect Immun 1995;63:865–873.
   PubMed Web of Science ®Google Scholar
• Reid RR, Prodeus AP, Khan W, et al. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol 1997;159:970–975.
   PubMed Web of Science ®Google Scholar
• Munford RS, Hall CL. Uptake and deacylation of bacterial lipopolysaccharides by macrophages from normal and endotoxin-hyporesponsive mice. Infect Immun 1985;48:464–473.
   PubMed Web of Science ®Google Scholar
• Cai L, Ji A, de Beer FC, et al. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest 2008;118:364–375.
   PubMed Web of Science ®Google Scholar
• Kleine B, Freudenberg MA, Galanos C. Excretion of radioactivity in faeces and urine of rats injected with 3H,14C-lipopolysaccharide. Br J Exp Pathol 1985;66:303–308.
   PubMedGoogle Scholar
• Kitchens RL, Wolfbauer G, Albers JJ, et al. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem 1999;274:34116–34122.
   PubMed Web of Science ®Google Scholar
• Kitchens RL, Wolfbauer G, Albers JJ, et al. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem 1999;274:34116–34122.
   PubMed Web of Science ®Google Scholar
• Thompson PA, Gauthier KC, Varley AW, et al. ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance. J Lipid Res 2010;51:2672–2685.
   PubMed Web of Science ®Google Scholar
• Peterson AA, Munford RS. Dephosphorylation of the lipid A moiety of Escherichia coli lipopolysaccharide by mouse macrophages. Infect Immun 1987;55:974– 978.
   PubMed Web of Science ®Google Scholar
• Fox ES, Thomas P, Broitman SA. Clearance of gut-derived endotoxins by the liver. Release and modification of 3H, 14C-lipopolysaccharide by isolated rat Kupffer cells. Gastroenterology 1989;96:456– 461.
   Google Scholar
• Wuorela M, Jalkanen S, Toivanen P, et al. Yersinia lipopolysaccharide is modified by human monocytes. Infect Immun 1993;61:5261–5270.
   PubMed Web of Science ®Google Scholar
• Forestier C, Moreno E, Pizarro-Cerda J, et al. Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J Immunol 1999;162:6784–6791.
   PubMed Web of Science ®Google Scholar
• Erwin AL, Munford RS. Deacylation of structurally diverse lipopolysaccharides by human acyloxyacyl hydrolase. J Biol Chem 1990;265:16444–16449.
   PubMed Web of Science ®Google Scholar
• Munford RS, Hall CL. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 1986;234:203–205.
   PubMed Web of Science ®Google Scholar
• Golenbock DT, Hampton RY, Qureshi N, et al. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991;266:19490–19498.
   PubMed Web of Science ®Google Scholar
• Kitchens RL, Munford RS. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biol Chem 1995;270:9904–9910.
   PubMed Web of Science ®Google Scholar
• Kitchens RL, Ulevitch RJ, Munford RS. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 1992;176:485–494.
   PubMed Web of Science ®Google Scholar
• Hajjar AM, Ernst RK, Tsai JH, et al. Human toll-like receptor 4 recognises host-specific LPS modifications. Nature Immunol 2003;3:354–359.
   PubMed Web of Science ®Google Scholar
• Shao B, Kitchens RL, Munford RS, et al. Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxin. Hepatology 2011;54:1051–1062.
   PubMed Web of Science ®Google Scholar
• Koyama I, Matsunaga T, Harada T, et al. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin Biochem 2002;35:455–461.
   PubMed Web of Science ®Google Scholar
• Poelstra K, Bakker WW, Klok PA, et al. Dephosphorylation of endotoxin by alkaline phosphatase in vivo. Am J Pathol 1997;151:1163–1169.
   PubMed Web of Science ®Google Scholar
• Poelstra K, Bakker WW, Klok PA, et al. A physiologic function for alkaline phosphatase: endotoxin detoxification. Lab Invest 1997;76:319–327.
   PubMed Web of Science ®Google Scholar
• Tuin A, Huizinga-Van der Vlag A, van Loenen-Weemaes AM, et al. On the role and fate of LPS-dephosphorylating activity in the rat liver. Am J Physiol Gastrointest Liver Physiol 2006;290:G377–G385.
   PubMed Web of Science ®Google Scholar
• Bates JM, Akerlund J, Mittge E, et al. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2007;2:371– 382.
   PubMed Web of Science ®Google Scholar
• Kaliannan K, Hamarneh SR, Economopoulos KP, et al. Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci USA 2013;110:7003–7008.
   PubMed Web of Science ®Google Scholar
• Levin J, Bang FB. Clottable protein in Limulus: its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh 1968;19:186.
   PubMedGoogle Scholar
• Gnauck A, Lentle RG, Kruger MC. The Limulus Amebocyte lysate assay may be unsuitable for detecting endotoxin in blood of healthy female subjects. J Immunol Methods 2015;416:146–156.
   PubMed Web of Science ®Google Scholar
• Tsukagoshi S, Hashimoto Y, Fujii G, et al. Krestin (PSK). Cancer Treat Rev 1984;11:131–155.
   PubMed Web of Science ®Google Scholar
• Digby J, Kalbfleisch J, Glenn A, et al. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 2003;10:882–885.
   PubMedGoogle Scholar
• Rossignol D, Lynn M, Wittek A, et al. Elevated plasma levels of limulus amoebocyte lysate- reactive material. Authors' reply. J Infect Dis 2006;194:1340–1341.
   Google Scholar
• Sonnenwirth AC, Yin ET, Sarmiento EM, et al. Bacterioidaceae endotoxin detection by Limulus assay. Am J Clin Nutr 1972;25:1452–1454.
   PubMed Web of Science ®Google Scholar
• Tiirola T, Jaakkola A, Bloigu A, et al. Novel enzyme immunoassay utilizing lipopolysaccharide-binding protein as a capture molecule for the measurement of chlamydial lipopolysaccharide in serum. Diagn Microbiol Infect Dis 2006;54:7–12.
   PubMed Web of Science ®Google Scholar
• Saxen H, Vuopio-Varkila J, Luk J, et al. Detection of enterobacterial lipopolysaccharides and experimental endotoxemia by means of an immunolimulus assay using both serotype-specific and cross-reactive antibodies. J Infect Dis 1993;168:393–399.
   PubMed Web of Science ®Google Scholar
• Jansson PE, Lindberg AA, Lindberg B, et al. Structural studies on the hexose region of the core in lipopolysaccharides from Enterobacteriaceae. Eur J Biochem 1981;115:571–577.
   PubMedGoogle Scholar
• Muller-Loennies S, BradeL MacKenzie CR, et al. Identification of a cross-reactive epitope widely present in lipopolysaccharide from enterobacteria and recognized by the cross-protective monoclonal antibody WN1 222–5. J Biol Chem 2003;278:25618–25627.
   PubMed Web of Science ®Google Scholar
• Romaschin AD, Harris DM, Ribeiro MB, et al. A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence. J Immunol Methods 1998;212:169–185.
   PubMed Web of Science ®Google Scholar
• Wood DM, Parent JB, Gazzano-Santoro H, et al. Reactivity of monoclonal antibody E5 with endotoxin. I. Binding to lipid A and rough lipopolysaccharides. Circ Shock 1992;38:55–62.
   PubMedGoogle Scholar
• Bhat NM, Bieber MM, Chapman CJ, et al. Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells. J Immunol 1993;151:5011–5021.
   PubMed Web of Science ®Google Scholar
• Fujihara Y, Bogard WC, Lei MG, et al. Monoclonal anti-lipid A IgM antibodies HA-1A and E-5 recognize distinct epitopes on lipopolysaccharide and lipid A. J Infect Dis 1993;168:1429–1435.
   PubMed Web of Science ®Google Scholar
• Warren HS, Amato SF, Fitting C, et al. Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med 1993;177:89–97.
   PubMed Web of Science ®Google Scholar
• Szponar B, Krasnik L, Hryniewiecki T, et al. Distribution of 3-hydroxy fatty acids in tissues after intraperitoneal injection of endotoxin. Clin Chem 2003;49:1149–1153.
   PubMed Web of Science ®Google Scholar
• Maitra KS, Schotz MC, Yoshikawa TT, et al. Determination of lipid A and endotoxin in serum by mass spectroscopy. Proc Natl Acad Sci USA 1978;75:3993– 3997.
   PubMed Web of Science ®Google Scholar
• Szponar B, Norin E, Midtvedt T, et al. Limitations in the use of 3-hydroxy fatty acid analysis to determine endotoxin in mammalian samples. J Microbiol Methods 2002;50:283–289.
   PubMed Web of Science ®Google Scholar
• Urbaschek R, McCuskey RS, Rudi V, et al. Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Alcohol Clin Exp Res 2001;25:261–268.
   PubMed Web of Science ®Google Scholar
• Bolke E, Jehle PM, Storck M, et al. Endotoxin release and endotoxin neutralizing capacity during colonoscopy. Clin Chim Acta 2001;303:49–53.
   PubMed Web of Science ®Google Scholar
• Berger D, Schleich S, Seidelmann M, et al. Correlation between endotoxin-neutralizing capacity of human plasma as tested by the limulus-amebocyte-lysate-test and plasma protein levels. FEBS Lett 1990;277:33–36.
   PubMed Web of Science ®Google Scholar
• Barclay GR, Scott BB. Serological relationships between Escherichia coli and Salmonella smooth and rough mutant lipopolysaccharides as revealed by enzyme linked immunosorbent assay for human immunoglobulin G anti-endotoxin antibodies. Infect Immun 1987;55:2706–2714.
   PubMed Web of Science ®Google Scholar
• Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, et al. Relationship of preoperative serum anti-endotoxin-core antibody levels and adverse outcomes following cardiac surgery. JAMA 1997;277:646–650.
   PubMed Web of Science ®Google Scholar
• Warshaw AL, Bellini CA, Walker WA. The intestinal mucosal barrier to intact antigenic protein. Difference between colon and small intestine. Am J Surg 1977;133:55–58.
   PubMed Web of Science ®Google Scholar
• Elmore RG, Vaillancourt DH, Berg JN, et al. Absorption of Escherichia coli endotoxin from the small intestines of mature non-pregnant gilts. Theriogenology 1981;16:659–667.
   Web of Science ®Google Scholar
• Imaeda H, Yamamoto H, Takaki A, et al. In vivo response of neutrophils and epithelial cells to lipopolysaccharide injected into the monkey ileum. Histochem Cell Biol 2002;118:381–388.
   PubMed Web of Science ®Google Scholar
• Pedersen HK, Gudmundsdottir V, Nielsen HB, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 2016;535:376–381.
   PubMed Web of Science ®Google Scholar
• augeretteF, VorsC, GéloënA, et al. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem 2010;22:53–59.
   PubMed Web of Science ®Google Scholar
• Harper MS, Carpenter C, Klocke DJ, et al. E. coli lipopolysaccharide: acute oral toxicity study in mice. Food Chem Toxicol 2011;49:1770–1772.
   PubMed Web of Science ®Google Scholar
• Berczi I, Bertok L, Baitner K, et al. Failure of oral Escherichia coli endotoxin to induce either specific tolerance or toxic symptoms in rats. J Pathol Bacteriol 1968;96:481–486.
   PubMedGoogle Scholar
• Aschenbach JR, Seidler T, Ahrens F, et al. Luminal salmonella endotoxin affects epithelial and mast cell function in the proximal colon of pigs. Scand J Gastroenterol 2003;38:719–726.
   PubMed Web of Science ®Google Scholar
• Kocsár LT, Bertók L, Várterész V. Effect of bile acids on the intestinal absorption of endotoxin in rats. J Bacteriol 1969;100:220–223.
   PubMed Web of Science ®Google Scholar
• Illyés G, Kovács K, Kocsis B, et al. Failure of oral E. coli O83 lipopolysaccharide to influence intestinal morphology and cell proliferation in rats: Short communication. Acta Vet Hung 2008;56:1–3.
   PubMed Web of Science ®Google Scholar
• Tamai H, Kato S, Horie Y, et al. Effect of acute ethanol administration on the intestinal absorption of endotoxin in rats. Alcohol Clin Exp Res 2000;24:390–394.
   PubMed Web of Science ®Google Scholar
• Yoshino S, Sasatomi E, Mori Y, et al. Oral administration of lipopolysaccharide exacerbates collagen-induced arthritis in mice. J Immunol 1999;163:3417–3422.
   PubMed Web of Science ®Google Scholar
• van Dijk A, Bauer J, Sedelmeier EA, et al. Absorption, kinetics, antibody-bound and free serum determination of a 14C-labeled Escherichia coli extract after single oral administration in rats. Arzneimittelforschung 1997;47:329–334.
   PubMed Web of Science ®Google Scholar
• Ravin HA, Rowley D, Jenkins C, et al. On the absorption of bacterial endotoxin from the gastro-intestinal tract of the normal and shocked animal. J Exp Med 1960;112:783–792.
   PubMed Web of Science ®Google Scholar
• Vodovotz Y, Liu S, McCloskey C, et al. The hepatocyte as a microbial product-responsive cell. J Endotoxin Res 2001;7:365–373.
   PubMedGoogle Scholar
• Movita D, Kreefft K, Biesta P, et al. Kupffer cells express a unique combination of phenotypic and functional characteristics compared with splenic and peritoneal macrophages. J Leukoc Biol 2012;92:723–733.
   PubMed Web of Science ®Google Scholar
• Erridge C. The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br J Nutr 2010;20:1–9.
   PubMed Web of Science ®Google Scholar